|
Post by lakon on May 16, 2016 9:49:46 GMT -5
"For me the real question right now isnt should I be waiting to sell..but should I be finding more money to put in?" Greed kills. Not sure who said that first, but I think it is good advice. On the other hand, Warren Buffett said, “Be Fearful When Others Are Greedy and Greedy When Others Are Fearful.”
|
|
|
Post by slugworth008 on May 16, 2016 9:59:15 GMT -5
good message.. but if I'm reading this right. (good chance I'm not)... to think MNKD could double or triple in 3 years is just ridiculous.. hell we went from ..70 to 2 bucks in a few weeks in March.. It can triple from here in 5-7 days on good news. Just based on if things go well.. not spectacular.. this stock will be 5-8 bucks in the next year. That's my take as well gamblerjag - We could easily be at 5-8 within the next year. Hell within the next 3-6 months for that matter. First survive then we thrive. IMO
|
|
|
Post by morfu on May 21, 2016 20:51:20 GMT -5
I am not sure if I can agree with that.. Sanofi put quite a bit of money on the table.. Assuming this 2nd round has a bigger success, who can tell that this isnt the result of the previous effort and no one would have gotten it flying faster!? Sanofi did Afrezza a good service by keeping it alive for that time This is utter nonsense. Sanofi sandbagged Afrezza, almost from day one, certainly from mid-summer on. They nearly killed the product and the company and poisoned the well on the way out the door. Nothing good came from that partnership. I wish Sanofi nothing but heartache and hurt. Perhaps we'll receive a claw back parting gift - don't hold your breath. Hmm, well google "Sanofi pays Mannkind" .. first hit: www.bloomberg.com/news/articles/2014-08-11/sanofi-to-pay-mannkind-up-to-925m-for-inhaled-insulinI aggree the probably wont pay 925mil now, but the 150mil upfront, the credit and the so far undisclosed milestone payments (why all this secrecy Mannkind!? The audacity not to disclose the reciever of the 50mil share giveaway while asking for another 150mil..).. this has not been cheap for Sanofi and was essential for Mannkind!
|
|
|
Post by cm5 on May 21, 2016 21:04:53 GMT -5
|
|
|
Post by cm5 on May 23, 2016 17:40:56 GMT -5
|
|
|
Post by cm5 on May 23, 2016 17:54:31 GMT -5
Apologies for above duplicate post---copied to another thread--
|
|
|
Post by sccrbrg on Jun 18, 2016 16:56:53 GMT -5
Just in continuation, I'm beginning to wonder when, I feel ever, we are going to see any 2.0 launch. It would be nice to see ANY advertising. Even on social media.
|
|
|
Post by agedhippie on Jun 18, 2016 17:17:04 GMT -5
Just in continuation, I'm beginning to wonder when, I feel ever, we are going to see any 2.0 launch. It would be nice to see ANY advertising. Even on social media. There is no point in advertising until the insurance position is fixed. Better to take the time while that is done to get the endos comfortable with the idea of Afrezza.
|
|
|
Post by mbseeking on Jun 18, 2016 19:46:26 GMT -5
Thought Mike C was pretty clear.. new sales team would start hitting the streets in July. He has become less clear on insurance but my understanding now is that they have dropped prices to PBMs (not sure it matches injectables) , put a PA assistance process in place to assist new endos/patients until the PBMs do their periodic reviews and adjust (hopefully improve) coverage. No money for advertising.. that will (may) come later..
So July. Not a ground shaking change in numbers, but yes, I would expect to see some new activity in the scripts by late July with it ramping Aug and Sep. Year end number? Who knows. Don't believe it has to be so big, but if they can get it higher than SNY's numbers then it invalidates anything SNY did and said and with that alone I believe the SP will be away.
|
|